Navigation Links
Wake Pharm US Announces Appointment of Jeffrey A. Niezgoda, M.D. to the Board of Medical Advisors
Date:6/28/2009

ELK GROVE VILLAGE, Ill., June 29 /PRNewswire/ -- Wake Pharm US announced today the appointment of Jeffrey A. Niezgoda, MD, FACHM, FACEP, FAPWCA as Director of the Company's Medical Advisory Board.

Dr. Jeffrey Niezgoda is a leading wound management physician and the Medical Director of the Centers for Comprehensive Wound Care and Hyperbaric Oxygen Therapy in Milwaukee, Wisconsin. He also serves as the President and Chief Operating Officer of Hyperbaric & Wound Care Associates, a medical specialty group serving Southeastern Wisconsin and Northern Illinois, and as the President of the American College of Hyperbaric Medicine.

Dr. Niezgoda stated, "I am very pleased to accept the position of Director of the Advisory Board and to have the opportunity to contribute to the company's clinical mission. My clinical experience with Wound Be Gone(R) has produced impressive results with improved wound healing trajectories. Wound Be Gone(R) is placing wound care into the hands of people who might otherwise suffer or whose wound problems might escalate to need for expensive invasive medical intervention."

Ludek Lolek, President & CEO of Wake Pharm US commented, "Dr. Niezgoda has been an invaluable resource to the Wound Be Gone(R) brand. His clinical insight and experience has been a tremendous asset to our development team. As Director of our Medical Advisory Board, Dr. Niezgoda will help us to accelerate the growth of our product line."

Wound-Be-Gone(R) is a novel hydrophilic gel that has been shown to demonstrate enhanced wound healing in varied clinical settings with both acute and chronic wounds. The mechanism of action appears to be related to a decrease in inflammatory mediators due to the active scavenging of oxygen free radicals. Visit www.woundbegone.com for more details.

About Wake Pharm US:

Wake Pharm US is an innovative and international company with its own manufacturing facility located in the Czech Republic (European Union). Wake Pharm US specializes in developing, marketing and distribution of revolutionary and unique products to the health marketplace. For further information about Wake Pharm US, please visit our website at www.wakepharmus.com.


'/>"/>
SOURCE Wake Pharm US
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Caraco Pharmaceutical Laboratories, Ltd. Updates on Financial Position
2. WuXi PharmaTech Files 2008 Annual Report on Form 20-F
3. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Action
4. Pharmacomechanical Thrombectomy Procedure Adoption to Accelerate Due to More Aggressive Treatment of Deep Vein Thrombosis, According to Millennium Research Group
5. Labopharm amends debt facility agreement with Hercules
6. Watson Pharmaceuticals Receives FDA Approval For Generic PLAN B(R)
7. The Crohns & Colitis Foundation and Procter & Gamble Pharmaceuticals Announce 2009 Celebrating UC Success Contest Winners
8. Peregrine Pharmaceuticals Awarded Broad New U.S. Patent for Vascular Imaging Applications of Its PS-Targeting Platform
9. DiaGenic to Provide MCI Biomarkers for Merz Pharmaceuticals
10. CNI Pharmacy Technician Program
11. RetireSafe Salutes Pharmaceutical Research and Manufacturers of America for Its Commitment to Cut Drug Prices and Help Seniors in the Medicare Doughnut-Hole
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... June 26, 2016 , ... Pixel Film Studios Released ... , "Film editors can give their videos a whole new perspective by using the ... CEO of Pixel Film Studios. , ProSlice Levels contains over 30 Different presets ...
(Date:6/26/2016)... , ... June 26, 2016 , ... ... once they have been diagnosed with endometriosis. These women need a treatment plan ... require a comprehensive approach that can help for preservation of fertility and ultimately ...
(Date:6/25/2016)... ... ... The temporary closing of Bruton Memorial Library on June 21 due to a possible lice ... overlooked aspect of head lice: the parasite’s ability to live away from a human host, ... a necessary one in the event that lice have simply gotten out of control. , ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. ... his M.D from the David Geffen School of Medicine at UCLA. He trained in ... to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he ...
(Date:6/25/2016)... ... 2016 , ... Conventional wisdom preaches the benefits of moderation, whether it’s a ... the bar too high can result in disappointment, perhaps even self-loathing. However, those who ... , Research from PsychTests.com reveals that behind the tendency to set ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... 2016 Research and Markets has ... by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), ... Parenteral) - Global Forecast to 2021" report to ... The global pharmaceutical excipients market is projected to reach ... 6.1% in the forecast period 2016 to 2021. ...
(Date:6/23/2016)... , June 23, 2016 ... CAPR ), a biotechnology company focused on ... today announced that patient enrollment in its ongoing ... Duchenne) has exceeded 50% of its 24-patient target. ... in the third quarter of 2016, and to ...
(Date:6/23/2016)... INDIANAPOLIS , June 23, 2016 ... Tomorrow,s Leaders Scholarship is any indication, the future is ... online at www.diabetesscholars.org by the Diabetes Scholars ... in the way of academic and community service excellence. ... program since 2012, and continues to advocate for people ...
Breaking Medicine Technology: